Articles

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia

Department of Hematology, Oncology and Tumor Immunology, Charité Universitätsmedizin Berlin, Germany
Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité Universitätsmedizin Berlin, Germany
Max Planck Genome Center, Köln, Germany
Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
Department of Medicine III (Hematology, Oncology), Ulm University, Munich, Germany
Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Munich, Germany
Department of Hematology, Klinikum München-Schwabing, Munich, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité Universitätsmedizin Berlin, Germany
Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt/Main, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité Universitätsmedizin Berlin, Germany
Vol. 102 No. 10 (2017): October, 2017 https://doi.org/10.3324/haematol.2016.161273